Safety and efficacy of tenofovir in chronic hepatitis B-related decompensated cirrhosis

doi:10.3748/wjg.v23.i13.2396

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 23, Issue 13

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7231)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-5) series.

Item

Count

PDF

536

WORD

411

HTML

3759

Figures (1-4)

143

Tables (1-5)

143

Sum=4992

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

916

Download

1323

Sum=2239

Apr 7, 2017 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (16)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Gastroenterol. Apr 7, 2017; 23(13): 2396-2403
Published online Apr 7, 2017. doi: 10.3748/wjg.v23.i13.2396

Full Size Figure Download Figure

Figure 3 The changes of the Child-Turcotte-Pugh and model for end-stage liver disease scores in the decompensated group after tenofovir disoproxil fumarate treatment for 12 mo. The mean Child-Turcotte-Pugh (CTP) score (8.0 ± 1.5 vs 6.3 ± 1.3) and model for end-stage liver disease (MELD) scores (13.4 ± 4.7 vs 10.5 ± 3.9) improved after 12 mo of tenofovir disoproxil fumarate treatment than at baseline (P < 0.001 for all). CTP: Child-Turcotte-Pugh; MELD: Model for End-stage Liver Disease.

Citation: Lee SK, Song MJ, Kim SH, Lee BS, Lee TH, Kang YW, Kim SB, Song IH, Chae HB, Ko SY, Lee JD. Safety and efficacy of tenofovir in chronic hepatitis B-related decompensated cirrhosis. World J Gastroenterol 2017; 23(13): 2396-2403
URL: https://www.wjgnet.com/1007-9327/full/v23/i13/2396.htm
DOI: https://dx.doi.org/10.3748/wjg.v23.i13.2396